MedImaging

Download Mobile App
Recent News Radiography MRI Ultrasound Nuclear Medicine General/Advanced Imaging Imaging IT Industry News

Next Generation Quantitative MRI Solution Offers Unprecedented Resolution and Accuracy in Brain Imaging

By MedImaging International staff writers
Posted on 29 Dec 2023

Magnetic Resonance Imaging (MRI) is the preferred method for visualizing soft tissues of the brain, but diagnosis is often based on subjective assessment. Now, a next-generation imaging solution with isotropic 3D resolution is poised to revolutionize the field of medical imaging by introducing a myriad of innovative applications within its post-processing solution.

SyntheticMR’s (Linköping, Sweden) new 3D release, SyMRI 3D, enables precise volumetric estimations of brain regions, a technique commonly referred to as parcellation, which empowers clinicians to gain deeper insights into brain structure and function. Furthermore, the exceptional resolution provided by SyMRI 3D facilitates comprehensive lesion analysis, ensuring a more accurate and in-depth assessment of medical conditions. The advanced SyMRI sequence introduces 3D resolution to quantitative values and tissue segmentations, ensuring the same level of precision in quantification as achieved with SyMRI's 2D imaging. SyMRI 3D has obtained approval in the EU and is now CE-Marked with preparations in place for its commercial launch at the start of 2024.


Image: SyMRI 3D has obtained approval in the EU and is now CE-Marked (Photo courtesy of SyntheticMR)
Image: SyMRI 3D has obtained approval in the EU and is now CE-Marked (Photo courtesy of SyntheticMR)

"We are delighted to see our 3D solution CE-marked and available on the European market," said Ulrik Harrysson, CEO at SyntheticMR AB. "SyMRI 3D represents the next generation of quantitative MRI, offering unprecedented resolution and accuracy in brain imaging, revolutionizing the landscape of medical diagnostics."

"This advanced sequence extends 3D resolution to quantitative values and tissue segmentations, matching the precision achieved in SyMRI's 2D imaging. The CE-marking for SyMRI 3D paves the way for physicians to make more informed decisions through quantitative imaging," added Kyle Frye, CCO & President of SyntheticMR Inc. "Receiving approval for SyMRI 3D will allow us to enable physicians to make better, more informed decisions using quantitative imaging."

Related Links:
SyntheticMR 


Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
CT Phantom
CIRS Model 610 AAPM CT Performance Phantom
New
Compact C-Arm
Arcovis DRF-C S21
New
X-Ray Detector
FDR-D-EVO III

Latest MRI News

Low-Cost Whole-Body MRI Device Combined with AI Generates High-Quality Results

World's First Whole-Body Ultra-High Field MRI Officially Comes To Market

World's First Sensor Detects Errors in MRI Scans Using Laser Light and Gas